Nursing care
Hydroxychloroquine: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Hydroxychloroquine, used for lupus, rheumatoid arthritis, and malaria prevention, requires a baseline eye examination and yearly follow-up because retinal toxicity is irreversible and produces no symptoms until damage is already advanced. This makes ophthalmic screening a non-negotiable part of long-term therapy.
Why this drug and not another
Hydroxychloroquine is a disease-modifying antirheumatic drug used for lupus and rheumatoid arthritis, and separately as antimalarial prophylaxis, working through distinct mechanisms depending on indication but sharing the same toxicity profile either way. It is often chosen for lupus because it is one of the few therapies shown to reduce flare frequency and improve long-term survival, not merely manage symptoms.
Compared with other DMARDs, it has a milder side effect profile in the short term and does not require the same intensity of blood monitoring as methotrexate, which is why it is frequently a first or early addition. Its trade-off is the long-term ocular risk that only becomes relevant with years of cumulative exposure.
Administration and timing
Hydroxychloroquine is typically taken daily or in a divided dose, with food to reduce gastrointestinal upset, and effects for autoimmune conditions build gradually over weeks to months rather than working immediately. Patients starting it for lupus or rheumatoid arthritis should be told not to expect quick symptom relief.
Dosing for chronic use is generally weight-based to limit cumulative exposure, since retinal toxicity risk correlates with both daily dose relative to body weight and duration of therapy, with risk rising notably after five years of continuous use. For malaria prophylaxis, dosing follows a different, shorter-term schedule tied to travel dates.
Monitoring parameters
The defining monitoring requirement is ophthalmologic: a baseline eye examination before starting therapy, then annual screening beginning at five years for most patients, or sooner if risk factors such as renal impairment, high dose, tamoxifen use, or pre-existing retinal disease are present. This screening typically includes visual field testing and optical coherence tomography, not just a standard vision check, because early retinal toxicity can be present before it affects visual acuity.
Baseline and periodic blood counts and liver function tests are reasonable given rare haematologic and hepatic effects, and a baseline ECG is considered in patients with cardiac risk factors because of a rare but serious risk of cardiomyopathy and QT prolongation with long-term use.
Adverse effects to report
Visual changes of any kind, including blurred vision, difficulty reading, missing areas in the field of vision, or trouble seeing in dim light, must be reported and investigated urgently, since retinal toxicity is irreversible once established and can continue progressing even after the drug is stopped. This is the effect that defines hydroxychloroquine's safety profile and the one patients are counselled on most heavily.
Muscle weakness can indicate a rare myopathy, and palpitations or dizziness warrant cardiac evaluation given the QT prolongation risk. Skin pigmentation changes and unusual bruising should also be reported, though these are less urgent than visual or cardiac symptoms.
Contraindications and cautions
Pre-existing retinopathy or maculopathy is a contraindication given the drug's own retinal toxicity risk, and known hypersensitivity to 4-aminoquinoline compounds rules it out. Caution is used in patients with G6PD deficiency, since haemolysis can occur, and in those on other QT-prolonging medications.
Renal impairment increases retinal toxicity risk because reduced clearance raises cumulative drug exposure, so dosing and monitoring intervals are adjusted accordingly. Long-term concurrent use with tamoxifen also raises retinal risk and prompts earlier or more frequent eye screening.
Teaching points the exam tests
The core fact tested is that hydroxychloroquine causes irreversible retinal damage that is asymptomatic in its early stages, which is why screening is scheduled proactively rather than triggered by patient-reported symptoms. A question describing a patient who feels fine and questions why they need an eye exam is testing whether you understand that silent progression is exactly the danger.
Expect scenario questions where a patient reports new visual disturbance and the correct action is prompt referral to ophthalmology, not reassurance that it will resolve. Questions may also test recognition that hydroxychloroquine's benefit for lupus and rheumatoid arthritis takes weeks to months to appear, distinguishing it from drugs with immediate effect.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why does hydroxychloroquine require regular eye exams?
Hydroxychloroquine can cause retinal toxicity that is irreversible once it develops and produces no symptoms in its early stages. A baseline eye exam before starting therapy and annual screening thereafter, usually from year five onward, allows damage to be caught before it affects vision.
How long does hydroxychloroquine take to work for lupus or rheumatoid arthritis?
It generally takes several weeks to a few months of consistent use before patients notice symptom improvement. Patients should be counselled to continue taking it as prescribed even without immediate relief, rather than assuming it isn't working.
What visual symptoms should a patient on hydroxychloroquine report immediately?
Blurred vision, difficulty reading, gaps in the visual field, or trouble seeing in low light should all prompt an urgent call to the prescriber and referral to ophthalmology. Because retinal damage from this drug is irreversible, early reporting matters far more than with most other side effects.
Is hydroxychloroquine safe in renal impairment?
It requires caution rather than outright avoidance in most cases, since reduced renal clearance increases cumulative drug exposure and raises the risk of retinal toxicity. Dosing adjustments and closer or earlier eye screening are typically used in this situation.
More on pharmacology
Guides on this